Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
ZOTA HEALTH CARE TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZOTA HEALTH CARE Mar-23 |
TEVA PHARMA Dec-13 |
ZOTA HEALTH CARE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 378 | 3,481 | - | |
Low | Rs | 225 | 3,024 | - | |
Sales per share (Unadj.) | Rs | 55.6 | 1,997.6 | - | |
Earnings per share (Unadj.) | Rs | -2.3 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | 2.5 | 286.3 | - | |
Dividends per share (Unadj.) | Rs | 1.00 | 109.24 | - | |
Avg Dividend yield | % | 0.3 | 3.4 | 9.9% | |
Book value per share (Unadj.) | Rs | 31.9 | 2,219.0 | - | |
Shares outstanding (eoy) | m | 25.16 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 1.6 | 332.9% | |
Avg P/E ratio | x | -131.3 | 26.1 | -503.9% | |
P/CF ratio (eoy) | x | 122.6 | 11.4 | 1,079.0% | |
Price / Book Value ratio | x | 9.4 | 1.5 | 643.7% | |
Dividend payout | % | -43.6 | 87.5 | -49.8% | |
Avg Mkt Cap | Rs m | 7,581 | 2,757,874 | 0.3% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 121 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,690.2 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.5 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,399 | 1,693,984 | 0.1% | |
Other income | Rs m | 26 | 0 | - | |
Total revenues | Rs m | 1,425 | 1,693,984 | 0.1% | |
Gross profit | Rs m | 72 | 463,899 | 0.0% | |
Depreciation | Rs m | 120 | 136,926 | 0.1% | |
Interest | Rs m | 26 | 33,273 | 0.1% | |
Profit before tax | Rs m | -47 | 293,700 | -0.0% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,798 | -0.0% | |
Tax | Rs m | 11 | -3,586 | -0.3% | |
Profit after tax | Rs m | -58 | 105,822 | -0.1% | |
Gross profit margin | % | 5.2 | 27.4 | 18.8% | |
Effective tax rate | % | -23.1 | -1.2 | 1,888.7% | |
Net profit margin | % | -4.1 | 6.2 | -66.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 842 | 1,144,111 | 0.1% | |
Current liabilities | Rs m | 405 | 997,761 | 0.0% | |
Net working cap to sales | % | 31.2 | 8.6 | 361.2% | |
Current ratio | x | 2.1 | 1.1 | 181.2% | |
Inventory Days | Days | 20 | 91 | 22.0% | |
Debtors Days | Days | 726 | 96 | 757.2% | |
Net fixed assets | Rs m | 728 | 553,293 | 0.1% | |
Share capital | Rs m | 252 | 4,170 | 6.0% | |
Net worth | Rs m | 804 | 1,881,695 | 0.0% | |
Long term debt | Rs m | 0 | 866,172 | 0.0% | |
Total assets | Rs m | 1,570 | 3,871,297 | 0.0% | |
Interest coverage | x | -0.8 | 9.8 | -8.4% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.9 | 0.4 | 203.6% | |
Return on assets | % | -2.0 | 3.6 | -56.9% | |
Return on equity | % | -7.2 | 5.6 | -127.7% | |
Return on capital | % | -2.6 | 4.9 | -53.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -20 | 269,933 | -0.0% | |
From Investments | Rs m | 147 | -95,648 | -0.2% | |
From Financial Activity | Rs m | -139 | -323,803 | 0.0% | |
Net Cashflow | Rs m | -12 | -149,518 | 0.0% |
Compare ZOTA HEALTH CARE With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare ZOTA HEALTH CARE With: FABINO LIFE BDH INDUS. VINEET LABORATORIES COLINZ LABOR J.B.CHEMICALS
Indian share markets continued the momentum as the session progressed and ended on firm footing.